What 9 Analyst Ratings Have To Say About Tandem Diabetes Care
Portfolio Pulse from Benzinga Insights
Over the past three months, nine analysts have published their opinions on Tandem Diabetes Care (NASDAQ:TNDM) stock. The average price target is $38.89, compared to the current price of $29.17, implying an upside. However, this average represents a 20.63% decrease from the previous average price target of $49.00.
August 21, 2023 | 12:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Analysts have given a mixed review of Tandem Diabetes Care's stock, with an average price target of $38.89, implying an upside. However, this is a decrease from the previous average price target.
The mixed reviews from analysts indicate uncertainty about the stock's future performance. While the average price target suggests an upside, the decrease from the previous average price target could indicate less confidence in the stock's potential for growth.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100